Understanding antipsychotic non-classical prescriptions: A quantitative and qualitative approach

Epidemiologia e Psichiatria Sociale

Volumn 17, Issue 3, 2008, Pages 236-241

  Veronese, Antonio ^a   Vivenza, Valerio ^a   Nosè, Michela ^a   Cipriani, Andrea ^a   Tansella, Michele ^a   Barbui, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Antipsychotics; Community psychiatric services; Epidemiology; Irrational prescriptions

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAINSTORMING; COMMUNITY CARE; CONSULTATION; DOCTOR PATIENT RELATION; DRUG FORMULARY; DRUG INDICATION; DRUG TREATMENT FAILURE; DRUG UTILIZATION; FEMALE; HUMAN; ITALY; LICENSING; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; OFF LABEL DRUG USE; PATIENT MONITORING; POLYPHARMACY; PRESCRIPTION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGISTER; RISK REDUCTION; SYMPTOMATOLOGY;

EID: 53849121659     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1121189X00001330     Document Type: Article

References (28)

1. Amaddeo F., Beecham J., Bonizzato P., Fenyo A., Knapp M. & Tansella M. (1997). The use of a case register to evaluate the costs of psychiatric care. Acta Psychiatrica Scandinavica 95, 189-198.
2. Ananth J. (2005). Long term antipsychotic polypharmacy is common among Medicaid recipients with schizophrenia. Evidence-Based Mental Health 8,55.
3. Barbui C. (2005). Evidence-based medicine and medicine-based evidence. Neurological Sciences 26, 145-146.
4. Barbui C., Ciuna A., Nosè M., Patten S.B., Stegagno M., Burti L., Amaddeo F. & Tansella M. (2004). Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice. Acta Psychiatrica Scandinavica 109, 275-278.
5. Barbui C., Nosè M., Rambaldelli G., Bonetto C., Levi D., Patten S. & Tansella M. (2005). Development of a registry for monitoring psychotropic drug prescriptions: aims, methods and implications for ordinary practice and research. International Journal of Methods in Psychiatric Research 14, 151-157.
6. Barbui C., Nosè M., Mazzi M.A., Thornicroft G., Schene A., Becker T., Bindman J., Leese M., Helm H., Koeter M., Weinmann S. & Tansella M. (2006). Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. International Clinical Psychopharmacology 21, 355-362.
7. Barbui C., Veronese A. & Cipriani A. (2007). Explanatory and Pragmatic Trials. Epidemiologia e Psichiatria Sociale 16(2), 124-125.
8. Biancosino B., Barbui C., Marmai L., Dona S. &. Grassi L. (2005). Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study. International Clinical Psychopharmacology 20, 305-309.
9. Bonetto C., Nosè M., & Barbui C. (2006). Generating drug exposure data from computer-based medical records. Computer Methods and Programs in Biomedicine 83, 120-124.
10. Centorrino F., Fogarty K.V., Sani G., Salvatore P., Cincotta S.L., Hennen J., Guzzetta F., Talamo A., Saadeh M.G. & Baldessarini R.J. (2005). Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Human Psychopharmacology 20, 485-492.
11. Ganguly R., Kotzan J.A., Miller L.S., Kennedy K. & Martin B.C. (2004). Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. Journal of Clinical Psychiatry 65, 1377-1388.
12. Kingsbury S., Yi D. & Simpson G. (2001). Rational and irrational polypharmacy. Psychiatric Services 52, 1033-1036.
13. Kogut S.J., Yam F. & Dufresne R. (2005). Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages. Journal of Managed Care Pharmacy 11, 17-24.
14. March J.S., Silva S.G., Compton S., Shapiro M., Califf R. & Krishnan R. (2005). The case for practical clinical trials in psychiatry. American Journal of Psychiatry 162, 836-846.
15. Mays N. & Pope C. (2000). Assessing quality in qualitative research. British Medical Journal 320,50-52.
16. National Institute for Clinical Excellence (2002). Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. NICE ed.
17. Percudani M., Barbui C., Fortino I., Tansella M., Petrovich L. (2006). Antidepressant and antipsychotic drug prescribing in Lombardy. Epidemiologia e Psichiatria Sociale 15(1), 58-69.
18. Pope C. & Mays N. (1995). Qualitative research: reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. British Medical Journal 311, 42-45.
19. Rijcken C., Boelema G.J., Slooff C., Beuger P.,Tanja T. & De Tong-van den Berg L.T. (2003). Off-label use of antipsychotics in the community pharmacy: the sex differences. Pharmacopsychiatry 36,186-191.
20. Schumacher J., Makela E. & Griffin H. (2003). Multiple antipsychotic medication prescribing pattern. Annals of Pharmacotherapy 37, 951-955.
21. Sernyak M.J. & Rosenheck R. (2004). Clinicians' reasons for antipsychotic coprescribing. Journal of Clinical Psychiatry 65, 1597-1600.
22. Stiles W. (1999). Evaluating qualitative research. Evidence-Based Mental Health 2, 99-101.
23. Tansella M. & Burti L. (2003). Integrating evaluative research and community-based mental health care in Verona, Italy. British Journal of Psychiatry 183, 167-169.
24. Tansella M., Amaddeo F., Burti L., Lasalvia A. & Ruggeri M. (2006a). Evaluating a community-based mental health service focusing on severe mental illness. The Verona experience. Acta Psychiatrica Scondinavica. Supplementum 429, 90-94.
25. Tansella M., Thornicroft G., Barbui C., Cipriani A. & Saraceno B. (2006b). Seven criteria for improving effectiveness trials in psychiatry. Psychological Medicine, 36, 711-720.
26. Tapp A., Wood A.E., Secrest L., Erdmann J., Cubberley L. & Kilzieh N. (2003). Combination antipsychotic therapy in clinical practice. Psychiatric Services 54, 55-59.
27. Treweek S., McCormack K., Abalos E., Campbell M., Ramsay C. & Zwarenstein M. (2006). The Trial Protocol Tool: The PRACTIHC software tool that supported the writing of protocols for pragmatic randomized controlled trials. Journal of Clinical Epidemiology 59, 1127-1133.
28. Weiss E., Hummer M., Koller D., Pharmd, Ulmer H. & Fleischhacker W.W. (2000). Off-label use of antipsychotic drugs. Journal of Clinical Psychopharmacology 20, 695-698.